BackAEON Biopharma Overview

AEON Biopharma Current Cash

Track AEON Biopharma's current cash ($6.2M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$6.24M
↓ 40.24% YoYΔ $-4.20M vs prior year quarter

Peer average

Loading

AEON Biopharma Current Cash History

Loading

AEON Biopharma vs. peers: Current Cash Comparison

Loading

AEON Biopharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AEON Biopharma (AEON) FAQ

AEON Biopharma (AEON) currently reports a current cash of $6.2M as of March 2026. That compares with $10M in the prior-year period — down 40.2% year over year. Use the charts on this page to explore AEON Biopharma's current cash history and peer comparisons.

AEON Biopharma's current cash decreased from $10M to $6.2M — a 40.2% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AEON Biopharma reported $6.2M in current cash as of March 2026. That compares with $10M in the prior-year period — down 40.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $6.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AEON Biopharma, and consider following AEON for alerts when major investors trade the stock.